Funding
Strategic · Climate tech

Epoch Biodesign raises $12m in strategic financing

Lululemon, Kompas VC, Happiness Capital, Extantia and Leitmotif participated in the enzyme-recycling company's round.

Updated Oct 16, 2026By RoundOS Funding desk

Epoch Biodesign raised $12 million in strategic financing on March 25. Participants included Lululemon, Kompas VC, Happiness Capital, Extantia and Leitmotif. The company develops enzymatic recycling technology to turn plastic waste into reusable resources.

Funding history

Strategic · This round$12M

Sources

  1. Epoch Biodesignprojectstartups.com
  2. tech.eu

Similar rounds

All Climate tech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Fairy Devices

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.

UndisclosedJICN equity investment · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026

Related